International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Exploration of Financial Fluctuation on Sun Pharma During and After Epidemic

Author(s) ANUVARSHINI SUMATHY RAMESH, SIVAPRAKASH J S
Country India
Abstract A significant part of the COVID-19 epidemic's medication supply is played by pharmaceutical companies. The biggest pharmaceutical company in India is a private business called SUN PHARMACEUTICAL INDUSTRIES LTD. Dilip Shanghvi was the company's founder. In Gujarat, he founded the company in 1983. It is currently the world's fourth-largest speciality generic pharmaceutical company. Sun Pharmaceutical gives medicines to the public for no charge during COVID-19 epidemic. Sun Pharmaceutical also donates a variety of tablets to other international locations. The financial progress of the Sun Pharmaceutical Company both during and after COVID-19 will be examined in this study.
To conduct the analysis, the researcher uses the relevant company's balance sheet. Several financial statement analysis tools will be used to complete this examination. The interpretation will show the company's financial development through time and its likelihood of survival going forward.
Keywords pharmaceutical company, specialty generic, balance sheet, financial analysis tools, financial developmen, epidemic.
Field Business Administration
Published In Volume 5, Issue 2, March-April 2023
Published On 2023-04-13
Cite This Exploration of Financial Fluctuation on Sun Pharma During and After Epidemic - ANUVARSHINI SUMATHY RAMESH, SIVAPRAKASH J S - IJFMR Volume 5, Issue 2, March-April 2023. DOI 10.36948/ijfmr.2023.v05i02.2355
DOI https://doi.org/10.36948/ijfmr.2023.v05i02.2355
Short DOI https://doi.org/gr5qwf
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com